MORRISVILLE, N.C.--(BUSINESS WIRE)--Clinical data on Arrivo Bio’s RABI-767 program will be presented at the 58th European Pancreatic Club (EPC)/International Association of Pancreatology (IAP) Annual Meeting, taking place June 24–27, 2026 in Istanbul, Turkey. The presentation will highlight RABI-767, a small molecule pancreatic lipase inhibitor in development for patients with predicted severe acute pancreatitis (SAP). RABI-767 is designed to inhibit pancreatic lipase activity and interrupt the